Why Furiex Pharmaceuticals Inc. Is an Instant Double

Shares of Furiex Pharmaceuticals (UNKNOWN: FURX.DX  ) exploded today, up 145% as the company released data that its drug treating a form of IBS that results in diarrhea passed its phase 3 trials, soundly beating a placebo at the higher dosing.

In this video, Motley Fool health-care analyst David Williamson discusses whether or not he thinks the drug will be approved and what the potential market size could be, and looks at just how high this stock could go.

What's the best way to play the highly volatile biotech space?
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2823700, ~/Articles/ArticleHandler.aspx, 7/31/2014 11:55:20 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 16,706.35 -174.01 -1.03%
S&P 500 1,944.55 -25.52 -1.30%
NASD 4,391.07 -71.83 -1.61%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

7/31/2014 11:38 AM
ABBV $52.86 Down -0.89 -1.66%
AbbVie Inc. CAPS Rating: *****
FURX.DX $0.00 Down +0.00 +0.00%
Furiex Pharmaceuti… CAPS Rating: **
GILD $91.81 Down -1.98 -2.12%
Gilead Sciences CAPS Rating: ****

Advertisement